Close

BRLI Financial Facts

Provision for Income Taxes: 7.91M
TOTAL OTHER (INCOME) EXPENSES - NET: 416K
See Full Income Statement

TOTAL SHAREHOLDERS' EQUITY: 179.27M
Capital Lease Obligations - Short-Term Portion: 2.89M
See Full Balance Sheet

Bio-Reference Laboratories Inc. (BRLI) Earnings

  |   Expand Research on BRLI
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -7.5% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -1.8% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
6/8/15 Q215 $0.38$0.44 -$0.06$224M$231.87M N/A Details
3/5/15 Q115 $0.24$0.32 -$0.08$209M$216.4M N/A Details
12/18/14 Q414 $0.66$0.63 +$0.03$227.6K$228.81K N/A Details
8/27/14 Q314 $0.55$0.53 +$0.02$222.05K$210.44K N/A Details
6/5/14 Q214 $0.37$0.32 +$0.05$201.4K$195.64K N/A Details
3/4/14 Q114 N/A$0.15 N/A N/A$175.52M N/A N/A N/A
12/19/13 Q413 $0.40$0.55 -$0.15$192.22M$188.96M N/A Details
8/29/13 Q313 $0.53$0.51 +$0.02$185.4M$183.5M N/A Details